Biotech stock GeneDx broke out after the FDA issued its first AI rules for medical devices. Globus Medical and GeneDx are in ...

This leading medical device maker is showing constructive action in a flat base and setting up for its next move.

Jefferies analyst Matthew Taylor maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of ...

Audubon, PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its ...

Globus said it will offer 33 unique itineraries to Italy in 2025, covering 13 regions, 99 cities and several travel styles.

B, consensus $2.66B. The company said, “The Company established its full year 2025 revenue guidance range of $2.66 billion to $2.69 billion and fully diluted non-GAAP earnings per share range between ...

Audubon, PA-based Globus Medical, Inc. is a medical device ... Additionally, the company could be a top pick for growth investors. GMED has a Growth Style Score of A, forecasting year-over-year ...

Audubon, PA-based Globus Medical, Inc. is a medical device ... With a solid Zacks Rank and top-tier Value and VGM Style Scores, GMED should be on investors' short list. Trillions of dollars ...

Audubon, PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its ...